JPWO2021062559A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021062559A5
JPWO2021062559A5 JP2022520062A JP2022520062A JPWO2021062559A5 JP WO2021062559 A5 JPWO2021062559 A5 JP WO2021062559A5 JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022520062 A JP2022520062 A JP 2022520062A JP WO2021062559 A5 JPWO2021062559 A5 JP WO2021062559A5
Authority
JP
Japan
Prior art keywords
methyl
dihydroxy
biphenyl
pentyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551066A5 (https=
JP2022551066A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051330 external-priority patent/WO2021062559A1/en
Publication of JP2022551066A publication Critical patent/JP2022551066A/ja
Publication of JPWO2021062559A5 publication Critical patent/JPWO2021062559A5/ja
Publication of JP2022551066A5 publication Critical patent/JP2022551066A5/ja
Pending legal-status Critical Current

Links

JP2022520062A 2019-10-02 2020-10-02 カンナビノイド誘導体 Pending JP2022551066A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962909363P 2019-10-02 2019-10-02
US62/909,363 2019-10-02
US202062966418P 2020-01-27 2020-01-27
US62/966,418 2020-01-27
PCT/CA2020/051330 WO2021062559A1 (en) 2019-10-02 2020-10-02 Cannabinoid derivatives

Publications (3)

Publication Number Publication Date
JP2022551066A JP2022551066A (ja) 2022-12-07
JPWO2021062559A5 true JPWO2021062559A5 (https=) 2023-10-11
JP2022551066A5 JP2022551066A5 (https=) 2023-10-11

Family

ID=75336687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520062A Pending JP2022551066A (ja) 2019-10-02 2020-10-02 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12325709B2 (https=)
EP (1) EP4037676A4 (https=)
JP (1) JP2022551066A (https=)
WO (1) WO2021062559A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
KR20240096817A (ko) 2020-05-19 2024-06-26 사이빈 아이알엘 리미티드 중수소화된 트립타민 유도체 및 사용 방법
WO2022105810A1 (zh) * 2020-11-17 2022-05-27 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
CA3237951A1 (en) * 2021-11-10 2023-05-19 Mahmoud Mohamed Abdrabo MOUSTAFA New cannabinoid-gabapentinoid conjugates and uses thereof
WO2024231957A1 (en) * 2023-05-11 2024-11-14 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) 2'-{heterocyclyl (aryl/alkyl) methyl}-cannabidiol compounds and process for preparation thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8749598A (en) * 1997-08-26 1999-03-16 Ihara Chemical Industry Co. Ltd. Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural an d horticultural use
WO2003091189A1 (en) 2002-04-25 2003-11-06 Virginia Commonwealth University Cannabinoids
MX2007001943A (es) 2004-08-17 2007-05-09 Galderma Res & Dev Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
EP2054383A2 (en) 2006-08-09 2009-05-06 SmithKline Beecham Corporation Novel compounds as antagonists or inverse agonists at opioid receptors
WO2008096769A1 (ja) 2007-02-08 2008-08-14 Daiichi Sankyo Company, Limited 置換されたセルコスポラミド誘導体を含有する医薬
RU2529484C2 (ru) 2008-05-05 2014-09-27 Санофи-Авентис Ациламино-замещенные производные конденсированных циклопентанкарбоновых кислот и их применение в качестве фармацевтических средств
JP5766617B2 (ja) 2009-02-20 2015-08-19 ユニバーシティ・オブ・カンザス 修飾された糖部分を有するノボビオシン類似体
US9254272B2 (en) 2011-11-30 2016-02-09 Sutter West Bay Hospitals Resorcinol derivatives
US9517989B2 (en) * 2012-10-17 2016-12-13 Northeastern University 2-cycloalkyl resorcinol cannabinergic ligands
EP2762134A1 (en) * 2013-02-04 2014-08-06 Bioversys AG Composition for treatment of pathogens that are resistant to tetracyclines
EA201690247A1 (ru) * 2013-07-18 2016-06-30 Новартис Аг Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения
EP2842933B1 (de) 2013-09-03 2015-07-29 Symrise AG Mischungen cannabinoider Verbindungen, deren Herstellung und Verwendung
US20180353461A1 (en) 2014-12-04 2018-12-13 Servicio Andaluz De Salud Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
BR112019003024A8 (pt) * 2016-08-18 2019-09-10 Canopy Growth Corp plantas e métodos para aumentar e diminuir a síntese de canabinoides
US10640482B2 (en) * 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
WO2019234728A1 (en) 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
WO2020051099A1 (en) 2018-09-03 2020-03-12 Genentech, Inc. Carboxamide and sulfonamide derivatives useful as tead modulators
EP3886910A4 (en) 2018-11-30 2022-07-27 Canopy Growth Corporation A CANNABINOID OR A CANNABIS-CONTAINING COMPOUND, PROCESS FOR THEIR PRODUCTION AND THEIR USE
CA3138732A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
WO2020198874A1 (en) * 2019-04-04 2020-10-08 Scf Pharma Inc. Cannabidiolic acid monoglycerides, derivatives, and uses thereof
EP3994129A4 (en) 2019-07-04 2023-01-04 Canopy Growth Corporation CANNABINOID DERIVATIVES
JP2022539400A (ja) 2019-07-04 2022-09-08 キャノピー グロウス コーポレイション カンナビノイド誘導体
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
US20220259221A1 (en) 2019-07-12 2022-08-18 Canopy Growth Corporation Cannabinoid derivatives
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP4038058A4 (en) 2019-10-02 2023-10-25 Canopy Growth Corporation Cannabinoid derivatives
US20230122510A1 (en) 2019-11-26 2023-04-20 Canopy Growth Corporation Cannabinoid derivatives
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
JP2023503330A (ja) 2019-11-26 2023-01-27 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021113958A1 (en) 2019-12-09 2021-06-17 Canopy Growth Corporation Cannabinoid derivatives
JP2023505517A (ja) 2019-12-09 2023-02-09 キャノピー グロウス コーポレイション カンナビノイド誘導体

Similar Documents

Publication Publication Date Title
TWI714951B (zh) 帽依賴性核酸內切酶抑制劑
TWI548616B (zh) 巨大戟萜醇-3-醯化物iii及巨大戟萜醇-3-胺基甲酸酯化物
JP6772141B2 (ja) ネクローシス阻害薬
ES2428492T3 (es) Moduladores del receptor 88 acoplado a proteína G
WO2010138901A1 (en) Carboxylic acid-containing compounds, derivatives thereof, and related methods of use
SK284068B6 (sk) Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie
JP2013507374A (ja) Gタンパク質共役受容体88の修飾因子
RU2012129737A (ru) Замещенные бензамидные производные
WO2016148145A1 (ja) ピラゾロ[1,5-a]ピリミジン化合物
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
US9902725B2 (en) Heterocyclic derivatives as RORgamma modulators
JPWO2021062559A5 (https=)
TWI252757B (en) HIV integrase inhibitors
JP7561978B2 (ja) ベンザミド類化合物及びその使用
CA2716961A1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
ES2601181T3 (es) Derivados de isoxazol-tiazol como agonistas inversos del receptor GABA A para su uso en el tratamiento de trastornos cognitivos
TWI616435B (zh) 苯基衍生物
JPWO2021062557A5 (https=)
FR2882365A1 (fr) Derives de 2-(1,5-diphenyl-1h-pyrazol-3-yl)-1,3,4-oxadiazole leur preparation et leur application en therapeutique
MX2014008604A (es) Nuevos derivados de morofolinilo utiles como inhibidores de mogat-2.
ES2311744T3 (es) Derivados de tetrahidronaftaleno como antagonistas del receptor vainilloide.
JPWO2021007663A5 (https=)
ES2363565T3 (es) Acetofenonas sustituidas útiles como inhibidores de pde4.
JP5037337B2 (ja) 置換されたシクロヘキシル−1,4−ジアミンの酸誘導体
JPWO2021102568A5 (https=)